chrX-110688628-T-C
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1
The NM_001143981.2(CHRDL1):āc.954A>Gā(p.Lys318=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.39 in 1,206,617 control chromosomes in the GnomAD database, including 70,319 homozygotes. There are 149,863 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (ā ā ).
Frequency
Genomes: š 0.49 ( 11256 hom., 14760 hem., cov: 22)
Exomes š: 0.38 ( 59063 hom. 135103 hem. )
Consequence
CHRDL1
NM_001143981.2 synonymous
NM_001143981.2 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.175
Genes affected
CHRDL1 (HGNC:29861): (chordin like 1) This gene encodes an antagonist of bone morphogenetic protein 4. The encoded protein may play a role in topographic retinotectal projection and in the regulation of retinal angiogenesis in response to hypoxia. Alternatively spliced transcript variants encoding different isoforms have been described. [provided by RefSeq, Jan 2009]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.54).
BP6
Variant X-110688628-T-C is Benign according to our data. Variant chrX-110688628-T-C is described in ClinVar as [Benign]. Clinvar id is 257558.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chrX-110688628-T-C is described in Lovd as [Benign]. Variant chrX-110688628-T-C is described in Lovd as [Likely_benign].
BP7
Synonymous conserved (PhyloP=0.175 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.782 is higher than 0.05.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CHRDL1 | NM_001143981.2 | c.954A>G | p.Lys318= | synonymous_variant | 9/12 | ENST00000372042.6 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CHRDL1 | ENST00000372042.6 | c.954A>G | p.Lys318= | synonymous_variant | 9/12 | 2 | NM_001143981.2 | A1 |
Frequencies
GnomAD3 genomes AF: 0.486 AC: 53247AN: 109485Hom.: 11253 Cov.: 22 AF XY: 0.463 AC XY: 14731AN XY: 31789
GnomAD3 genomes
AF:
AC:
53247
AN:
109485
Hom.:
Cov.:
22
AF XY:
AC XY:
14731
AN XY:
31789
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.343 AC: 62789AN: 183161Hom.: 9185 AF XY: 0.334 AC XY: 22558AN XY: 67633
GnomAD3 exomes
AF:
AC:
62789
AN:
183161
Hom.:
AF XY:
AC XY:
22558
AN XY:
67633
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.380 AC: 417218AN: 1097085Hom.: 59063 Cov.: 31 AF XY: 0.372 AC XY: 135103AN XY: 362769
GnomAD4 exome
AF:
AC:
417218
AN:
1097085
Hom.:
Cov.:
31
AF XY:
AC XY:
135103
AN XY:
362769
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.486 AC: 53278AN: 109532Hom.: 11256 Cov.: 22 AF XY: 0.463 AC XY: 14760AN XY: 31846
GnomAD4 genome
AF:
AC:
53278
AN:
109532
Hom.:
Cov.:
22
AF XY:
AC XY:
14760
AN XY:
31846
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 30, 2024 | - - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | PreventionGenetics, part of Exact Sciences | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at